MedTrace Logo

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

NCT00331851 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 584

Last updated 2017-01-26

No results posted yet for this study

Summary

This trial is conducted in Africa, Asia, Europe and South America. This trial is designed to show the effect of treatment with liraglutide added to existing glimepiride and metformin combination therapy and to compare it with the effects of insulin glargine added to combination therapy of glimepiride and metformin.

Conditions

Interventions

DRUG

liraglutide

DRUG

insulin glargine

DRUG

metformin

DRUG

glimepiride

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2007-04-30
Completion
2007-04-30

Countries

  • Argentina
  • Austria
  • Brazil
  • Denmark
  • Finland
  • France
  • India
  • Italy
  • Netherlands
  • Norway
  • Philippines
  • Poland
  • Russia
  • Serbia and Montenegro
  • Slovakia
  • South Africa
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00331851 on ClinicalTrials.gov